+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomatlante SA - Product Pipeline Analysis, 2020 Update

  • PDF Icon

    Company Profile

  • 22 Pages
  • January 2021
  • GlobalData
  • ID: 4539817
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration. The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw and membrane, among others. Its products are used in stomatology, dental regenerative, sports surgery, spine surgery and orthopaedics. Biomatlante’s leverages Micro Macroporous Biphasic Calcium Phosphate (MBCP) technology for the development of products. The company works in collaboration with universities and research centers such as National Institute of Health and Medical Research, French National Center for Scientific Research, and other national and international universities for the development of novel projects. Biomatlante is headquartered in Vigneux de Bretagne, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biomatlante SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Biomatlante SA Company Overview
  • Biomatlante SA Company Snapshot
  • Biomatlante SA Pipeline Products and Ongoing Clinical Trials Overview

Biomatlante SA - Pipeline Analysis OverviewBiomatlante SA - Key FactsBiomatlante SA - Major Products and Services
Biomatlante SA Pipeline Products by Development Stage
  • Biomatlante SA Pipeline Products Overview
  • Biological Grafts
  • Biological Grafts Product Overview
  • Gene-Activated Matrix
  • Gene-Activated Matrix Product Overview
  • Hydrogels
  • Hydrogels Product Overview
  • Osteoconductive Resorbable Composite
  • Osteoconductive Resorbable Composite Product Overview

Biomatlante SA - Key CompetitorsBiomatlante SA - Key Employees
Biomatlante SA - Locations And Subsidiaries
  • Head Office

Recent Developments
  • Biomatlante SA, Recent Developments
  • Jun 01, 2015: BIOMATLANTE obtains CE approval to market its OSTEOTWIN Affix Sheath
  • Jan 17, 2013: Biomatlante Gets ANSM Approval For REBORNE Project
  • Oct 25, 2012: Biomatlante Announces Successful FDA QSIT Inspection

  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
  • Biomatlante SA Pipeline Products and Ongoing Clinical Trials Overview
  • Biomatlante SA Pipeline Products by Equipment Type
  • Biomatlante SA Pipeline Products by Indication
  • Biomatlante SA, Key Facts
  • Biomatlante SA, Major Products and Services
  • Biomatlante SA Number of Pipeline Products by Development Stage
  • Biomatlante SA Pipeline Products Summary by Development Stage
  • Biological Grafts - Product Status
  • Biological Grafts - Product Description
  • Gene-Activated Matrix - Product Status
  • Gene-Activated Matrix - Product Description
  • Hydrogels - Product Status
  • Hydrogels - Product Description
  • Osteoconductive Resorbable Composite - Product Status
  • Osteoconductive Resorbable Composite - Product Description
  • Biomatlante SA, Key Employees
  • Glossary

List of Figures
  • Biomatlante SA Pipeline Products by Equipment Type
  • Biomatlante SA Pipeline Products by Development Stage

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Teknimed SA
  • Synergie Ingenierie Medicale SARL
  • S.B.M Science For Bio Materials
  • KISCO International
  • Graftys SA
  • Abelgam Medical SARL